Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

TERN holding history

Terns Pharmaceuticals, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TERN overviewAll 13F holders of TERNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of TERN by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,218,810−100.0%Sold outHolders
Q1 20263,218,810$169.7M0.1%+52,168+1.6%AddedHolders
Q4 20253,166,642$127.9M0.1%+1,577,308+99.2%AddedHolders
Q3 20251,589,334$11.9M<0.1%−2,309,677−59.2%ReducedHolders
Q2 20253,899,011$14.5M<0.1%−8,876−0.2%ReducedHolders
Q1 20253,907,887$10.8M<0.1%+640,108+19.6%AddedHolders
Q4 20243,267,779$18.1M<0.1%−405,447−11.0%ReducedHolders
Q3 20243,673,226$30.6M<0.1%+2,213,276+151.6%AddedHolders
Q2 20241,459,950$9.94M<0.1%−1,505,636−50.8%ReducedHolders
Q1 20242,965,586$19.5M<0.1%+2,930,946+8,461.2%AddedHolders
Q4 202334,640$224.8K<0.1%−41,102−54.3%ReducedHolders
Q3 202375,742$381.0K<0.1%+74,286+5,102.1%AddedHolders
Q2 20231,456$12.7K<0.1%−390,609−99.6%ReducedHolders
Q1 2023392,065$4.64M<0.1%−123,732−24.0%ReducedHolders
Q4 2022515,797$5.25M<0.1%+515,797NewHolders
Q3 20220$00.0%−38,810−100.0%Sold outHolders
Q2 202238,810$96.0K<0.1%+38,810NewHolders
Q3 20210$00.0%−18,200−100.0%Sold outHolders
Q2 202118,200$223.0K<0.1%−14,421−44.2%ReducedHolders
Q1 202132,621$718.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.